Eli Lilly and Company (LLY.F) Stock Price, News & Chart

	LLY.F	0QCV.IL	BMY	BIIB	0QYQ.IL	AZN
Market cap	1.13T	535.73B	131.21B	37.61B	215.56B	293.14B
P/E (TTM)	48.0	61.3	14.2	110.2	39.8	26.7
Forward P/E	60.0	—	9.6	15.6	—	16.7
Price/book	31.7	40.9	5.6	2.0	10.2	5.7
Dividend yield	0.49%	4.05%	3.93%	—	3.81%	1.69%
1-year change	+55.23%	+33.33%	+32.80%	+62.24%	+38.91%	+13.30%
Today	+0.70%	+4.86%	+4.02%	+2.22%	+0.58%	+2.79%

Market cap

1.13T

535.73B

131.21B

37.61B

215.56B

293.14B

P/E (TTM)

48.0

61.3

14.2

110.2

39.8

26.7

Forward P/E

60.0

—

9.6

15.6

—

16.7

Price/book

31.7

40.9

5.6

2.0

10.2

5.7

Dividend yield

0.49%

4.05%

3.93%

—

3.81%

1.69%

1-year change

+55.23%

+33.33%

+32.80%

+62.24%

+38.91%

+13.30%

Today

+0.70%

+4.86%

+4.02%

+2.22%

+0.58%

+2.79%

Company	Mkt cap	Price	Today
AbbVie Inc.0QCV.IL · Drug Manufacturers - General	535.73B	297.80	+4.86%
Bristol-Myers Squibb CompanyBMY · Drug Manufacturers - General	131.21B	64.19	+4.02%
Biogen Inc.BIIB · Drug Manufacturers - General	37.61B	254.46	+2.22%
Gilead Sciences, Inc.0QYQ.IL · Drug Manufacturers - General	215.56B	173.00	+0.58%
AstraZeneca PLCAZN · Drug Manufacturers - General	293.14B	189.01	+2.79%
Chugai Pharmaceutical Co., Ltd.CUP.F · Drug Manufacturers - General	65.86B	40.02	+4.33%
Orion OyjOFK.F · Drug Manufacturers - General	14.28B	101.70	+2.99%
Celltrion, Inc.068270.KS · Biotechnology	49.02T	215,000.00	+7.50%

Company	Mkt cap	Price	Today
Novo Nordisk A/SNOVO-B.CO · Bagsvaerd, Denmark	1.26T	285.20	+5.57%
Ono Pharmaceutical Co., Ltd.4528.T · Osaka, Japan	1.17T	2,489.00	+4.62%
Gilead Sciences, Inc.GILD34.SA · Foster City, CA	1.19T	79.85	+3.33%
Pfizer Inc.PFIZ34.SA · New York, NY	953.24B	41.81	+1.38%
Bayer AktiengesellschaftBAYNN.MX · Leverkusen, Germany	936.33B	953.08	0.00%
Amgen Inc.AMGN34.SA · Thousand Oaks, CA	1.42T	93.78	+3.49%
JOHNSON & JOHNSON CDR (CAD HEDGJNJ.NE · New Brunswick, NJ	915.54B	35.27	+4.32%
Biogen Inc.BIIB.MX · Cambridge, MA	693.22B	4,689.60	0.00%

Company	Mkt cap	Price	Today
Novo Nordisk A/S0QIU.IL · Biotechnology	1.17T	277.80	−0.91%
Dr. Reddy's Laboratories LimitedDRREDDY.NS · Drug Manufacturers - Specialty & Generic	1.14T	1,366.00	−0.58%
Cipla LimitedCIPLA.NS · Drug Manufacturers - Specialty & Generic	1.13T	1,404.10	+0.15%
Lenskart Solutions LimitedLENSKART.BO · Medical Instruments & Supplies	1.24T	718.40	+3.97%
Daewoong Pharmaceutical Co., Ltd069620.KS · Drug Manufacturers - Specialty & Generic	1.23T	106,700.00	+3.69%
Sysmex Corporation6869.T · Medical Devices	1.21T	2,017.00	+3.70%
Ono Pharmaceutical Co., Ltd.4528.T · Drug Manufacturers - General	1.17T	2,489.00	+4.62%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP.BO · Medical Care Facilities	1.20T	8,359.05	−2.54%

Company	Mkt cap	Price	Today
Simon Property Group, Inc.SPG · Indianapolis, IN	86.74B	228.50	+2.89%
Elevance Health, Inc.ELV · Indianapolis, IN	94.16B	434.18	+4.94%
Elanco Animal Health IncorporatedELAN · Indianapolis, IN	12.64B	25.31	+3.01%
Allison Transmission Holdings, Inc.ALSN · Indianapolis, IN	9.95B	120.52	+1.35%
Corteva, Inc.CTVA · Indianapolis, IN	8.18B	12.26	+3.20%
Kite Realty Group TrustKRG · Indianapolis, IN	5.32B	25.91	+1.93%
Calumet, Inc.CLMT · Indianapolis, IN	3.83B	43.60	−7.88%
Hurco Companies, Inc.HURC · Indianapolis, IN	137.56M	21.24	−3.63%

Company	Mkt cap	Price	Today
Santen Pharmaceutical Co., Ltd.4536.T · life sciences	604.65B	1,882.00	+4.79%
Innovent Biologics, Inc.1801.HK · life sciences	154.42B	88.550	+4.12%
Takeda Pharmaceutical Company Limited4502.T · life sciences	11.00T	6,888.00	+4.55%
Aurobindo Pharma LimitedAUROPHARMA.BO · life sciences	1.04T	1,788.30	+5.13%
Glenmark Pharmaceuticals LimitedGLENMARK.BO · life sciences	701.47B	2,485.50	−0.65%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd1276.HK · life sciences	350.78B	52.850	+2.32%
KYORIN Pharmaceutical Co., Ltd.4569.T · life sciences	66.01B	1,149.00	+4.64%
Gilead Sciences, Inc.GIS.F · life sciences	191.58B	154.46	+0.89%

Company	Mkt cap	Price	Today
Johnson & JohnsonJNJ · Correlation 0.44	665.19B	276.32	+3.81%
AstraZeneca PLCAZN · Correlation 0.41	293.14B	189.01	+2.79%
Bristol-Myers Squibb CompanyBMY · Correlation 0.39	131.21B	64.19	+4.02%
Biogen Inc.BIIB · Correlation 0.37	37.61B	254.46	+2.22%

CoinCentral·3h agoNegative

Cathie Wood’s ARK Sells Amazon, Alphabet and Eli Lilly While Adding Nurix Therapeutics

Cathie Wood’s ARK Invest published its daily trades for Wednesday, November 4, 2026. The list covered technology, space and biotech holdings. Two reports on the day’s largest trade do not agree. Both say 348,406 SpaceX shares were…

NVDA SPCX AMZN

Kiplinger·4h agoPositive

Healthcare Stocks Are on the Mend. Here Are 6 Ways Investors Can Cash In

Boosted mainly by biotech, the healthcare sector is recuperating from its years-long malaise. Healthcare stocks are flying. Over the past 12 months, the sector has gained 23%, outpacing the 15.7% return in the S&P 500 Index. It's about…

LLY JNJ MRNA UNH

Opening Bell Daily·17h agoPositive

Macro Investor Jordi Visser Says AI Is the Only Macro Story and Explains His Bull Case for Eli Lilly and Micron

Visser tells Full Signal why AI is driving rates, what Microsoft's buyouts mean for labor, and where he sees upside. Jordi Visser, head of AI Macro Nexus Research at 22V Research and a former president and CIO of Weiss Multi-Strategy…

NVDA MSFT AMZN GOOGL

BioSpace·3h agoPositive

Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts

BioSpace Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts CAMBRIDGE, Mass.--(BUSINESS WIRE)--$AMLX--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx”

LLY NVO AZN

Devdiscourse·6h ago

Reuters Health News Summary

AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter.…

LLY JNJ UNH MRNA

Seeking Alpha·20h agoPositive

Eli Lilly: The True Frontier Of Real-World AI Monetization

(NYSE:LLY) Seeking Alpha - Eli Lilly is positioned as the primary beneficiary of AI-driven drug discovery, leveraging its scale and research infrastructure. - LLY's integration of AI accelerates new molecule development, enabling rapid…

NVDA META SPCX MSFT

Kalkine India·4h ago

GlaxoSmithKline Pharmaceuticals NSE:GLAXO Analyst Meet 2026

Kalkine India GlaxoSmithKline Pharmaceuticals (NSE:GLAXO): What Did the Analyst Meet Presentation Cover? Source: Krish Capital Pty Ltd GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) submitted a regulatory filing to both BSE and NSE on

MRK LLY JNJ PFE

Seeking Alpha·21h agoPositive

Eli Lilly: Higher Volume, Lower Realized Prices

Pharmaceutical company Eli Lilly and Company (LLY) reported volume growth of 53% last quarter against a 15% decline in realized prices. Revenue rose 39%. Gross margin went up year-over-year, too. That combination is unusual Best Stocks Now…

LLY NVO PFE

Sports Business Journal·11h agoPositive

Excel Sports Management adds key accounts with Deloitte, Eli Lilly

Sports Business Journal Excel Sports Management adds key accounts with Deloitte, Eli Lilly Acclamation should be extended to Excel Sports Management for noteworthy agency of record wins in two recent RFPs. Industry sources tell us E

LLY

foreignpolicyjournal.com·11h agoPositive

GENFIT’s (Euronext: GNFT) MASH Diagnostic Tool Draws Novo Nordisk, Eli Lilly And Madrigal As Medicare Coverage Milestone Reshapes Treatment Landscape

By David Prior | Nov 4, 2026 | Economy & Business, Featured, News & Analysis With Medicare reimbursement for its NASHnext® test having taken effect in August, GENFIT finds itself at the center of a rapidly shifting commercial landscape for…

TMO NVDA ABT INTC

Days on the list

30 d

1 yr

Best

Trending

—

Install

Eli Lilly and Company

Key statistics

Against its peers

Latest news